Cargando…

Alpha-Glucosidase and Alpha-Amylase Inhibitory Activities, Molecular Docking, and Antioxidant Capacities of Plectranthus ecklonii Constituents

Shortage in insulin secretion or degradation of produced insulin is the principal characteristic of the metabolic disorder of diabetes mellitus (DM). However, because the current medications for the treatment of DM have many detrimental side effects, it is necessary to develop more effective antidia...

Descripción completa

Detalles Bibliográficos
Autores principales: Etsassala, Ninon G. E. R., Badmus, Jelili A., Marnewick, Jeanine L., Egieyeh, Samuel, Iwuoha, Emmanuel. I., Nchu, Felix, Hussein, Ahmed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869333/
https://www.ncbi.nlm.nih.gov/pubmed/35204260
http://dx.doi.org/10.3390/antiox11020378
_version_ 1784656472871796736
author Etsassala, Ninon G. E. R.
Badmus, Jelili A.
Marnewick, Jeanine L.
Egieyeh, Samuel
Iwuoha, Emmanuel. I.
Nchu, Felix
Hussein, Ahmed A.
author_facet Etsassala, Ninon G. E. R.
Badmus, Jelili A.
Marnewick, Jeanine L.
Egieyeh, Samuel
Iwuoha, Emmanuel. I.
Nchu, Felix
Hussein, Ahmed A.
author_sort Etsassala, Ninon G. E. R.
collection PubMed
description Shortage in insulin secretion or degradation of produced insulin is the principal characteristic of the metabolic disorder of diabetes mellitus (DM). However, because the current medications for the treatment of DM have many detrimental side effects, it is necessary to develop more effective antidiabetic drugs with minimal side effects. Alpha-glucosidase and alpha-amylase inhibitors are directly implicated in the delay of carbohydrate digestion. Pharmacologically, these inhibitors could be targeted for the reduction in glucose absorption rate and, subsequently, decreasing the postprandial rise in plasma glucose and the risk for long-term diabetes complications. The main objectives of this research study were to isolate different phytochemical constituents present in the methanolic extract of Plectranthus ecklonii and evaluate their alpha-glucosidase and alpha-amylase inhibitory activities and antioxidant capacity. The phytochemical investigation of the methanolic extract of P. ecklonii yielded three known compounds, viz. parvifloron D, F, and G (1–3, respectively). Parvifloron G was isolated for the first time from P. ecklonii. The in vitro bio-evaluation of the methanolic extract of P. ecklonii and its isolated compounds against alpha-glucosidase showed that 3 exhibited moderate inhibitory activity with IC(50) values of 41.3 ± 1.2 μg/mL. Molecular docking analysis confirmed the alpha-glucosidase inhibitory activity demonstrated by 3. Additionally, strong antioxidant capacities were demonstrated by 3 and 1 on ORAC (28726.1 ± 8.1; 3942.9.6.6 ± 0.1 µM TE/g), respectively, which were comparable with the reference antioxidant epigallocatechingallate (EGCG). Furthermore, 3 also showed strong activity on TEAC (3526.1 ± 0.6 µM TE/g), followed by 2 (1069.3 ± 2.4 µM TE/g), as well as on FRAP (1455.4 ± 2.0 µM AAE/g). The methanolic extract of P. ecklonii is a rich source of abietane diterpenes with strong antioxidant activities. This is the first scientific report on alpha-glucosidase and alpha-amylase inhibitory activities, molecular docking, and antioxidant capacities of P. ecklonii constituents.
format Online
Article
Text
id pubmed-8869333
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88693332022-02-25 Alpha-Glucosidase and Alpha-Amylase Inhibitory Activities, Molecular Docking, and Antioxidant Capacities of Plectranthus ecklonii Constituents Etsassala, Ninon G. E. R. Badmus, Jelili A. Marnewick, Jeanine L. Egieyeh, Samuel Iwuoha, Emmanuel. I. Nchu, Felix Hussein, Ahmed A. Antioxidants (Basel) Article Shortage in insulin secretion or degradation of produced insulin is the principal characteristic of the metabolic disorder of diabetes mellitus (DM). However, because the current medications for the treatment of DM have many detrimental side effects, it is necessary to develop more effective antidiabetic drugs with minimal side effects. Alpha-glucosidase and alpha-amylase inhibitors are directly implicated in the delay of carbohydrate digestion. Pharmacologically, these inhibitors could be targeted for the reduction in glucose absorption rate and, subsequently, decreasing the postprandial rise in plasma glucose and the risk for long-term diabetes complications. The main objectives of this research study were to isolate different phytochemical constituents present in the methanolic extract of Plectranthus ecklonii and evaluate their alpha-glucosidase and alpha-amylase inhibitory activities and antioxidant capacity. The phytochemical investigation of the methanolic extract of P. ecklonii yielded three known compounds, viz. parvifloron D, F, and G (1–3, respectively). Parvifloron G was isolated for the first time from P. ecklonii. The in vitro bio-evaluation of the methanolic extract of P. ecklonii and its isolated compounds against alpha-glucosidase showed that 3 exhibited moderate inhibitory activity with IC(50) values of 41.3 ± 1.2 μg/mL. Molecular docking analysis confirmed the alpha-glucosidase inhibitory activity demonstrated by 3. Additionally, strong antioxidant capacities were demonstrated by 3 and 1 on ORAC (28726.1 ± 8.1; 3942.9.6.6 ± 0.1 µM TE/g), respectively, which were comparable with the reference antioxidant epigallocatechingallate (EGCG). Furthermore, 3 also showed strong activity on TEAC (3526.1 ± 0.6 µM TE/g), followed by 2 (1069.3 ± 2.4 µM TE/g), as well as on FRAP (1455.4 ± 2.0 µM AAE/g). The methanolic extract of P. ecklonii is a rich source of abietane diterpenes with strong antioxidant activities. This is the first scientific report on alpha-glucosidase and alpha-amylase inhibitory activities, molecular docking, and antioxidant capacities of P. ecklonii constituents. MDPI 2022-02-14 /pmc/articles/PMC8869333/ /pubmed/35204260 http://dx.doi.org/10.3390/antiox11020378 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Etsassala, Ninon G. E. R.
Badmus, Jelili A.
Marnewick, Jeanine L.
Egieyeh, Samuel
Iwuoha, Emmanuel. I.
Nchu, Felix
Hussein, Ahmed A.
Alpha-Glucosidase and Alpha-Amylase Inhibitory Activities, Molecular Docking, and Antioxidant Capacities of Plectranthus ecklonii Constituents
title Alpha-Glucosidase and Alpha-Amylase Inhibitory Activities, Molecular Docking, and Antioxidant Capacities of Plectranthus ecklonii Constituents
title_full Alpha-Glucosidase and Alpha-Amylase Inhibitory Activities, Molecular Docking, and Antioxidant Capacities of Plectranthus ecklonii Constituents
title_fullStr Alpha-Glucosidase and Alpha-Amylase Inhibitory Activities, Molecular Docking, and Antioxidant Capacities of Plectranthus ecklonii Constituents
title_full_unstemmed Alpha-Glucosidase and Alpha-Amylase Inhibitory Activities, Molecular Docking, and Antioxidant Capacities of Plectranthus ecklonii Constituents
title_short Alpha-Glucosidase and Alpha-Amylase Inhibitory Activities, Molecular Docking, and Antioxidant Capacities of Plectranthus ecklonii Constituents
title_sort alpha-glucosidase and alpha-amylase inhibitory activities, molecular docking, and antioxidant capacities of plectranthus ecklonii constituents
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869333/
https://www.ncbi.nlm.nih.gov/pubmed/35204260
http://dx.doi.org/10.3390/antiox11020378
work_keys_str_mv AT etsassalaninonger alphaglucosidaseandalphaamylaseinhibitoryactivitiesmoleculardockingandantioxidantcapacitiesofplectranthuseckloniiconstituents
AT badmusjelilia alphaglucosidaseandalphaamylaseinhibitoryactivitiesmoleculardockingandantioxidantcapacitiesofplectranthuseckloniiconstituents
AT marnewickjeaninel alphaglucosidaseandalphaamylaseinhibitoryactivitiesmoleculardockingandantioxidantcapacitiesofplectranthuseckloniiconstituents
AT egieyehsamuel alphaglucosidaseandalphaamylaseinhibitoryactivitiesmoleculardockingandantioxidantcapacitiesofplectranthuseckloniiconstituents
AT iwuohaemmanueli alphaglucosidaseandalphaamylaseinhibitoryactivitiesmoleculardockingandantioxidantcapacitiesofplectranthuseckloniiconstituents
AT nchufelix alphaglucosidaseandalphaamylaseinhibitoryactivitiesmoleculardockingandantioxidantcapacitiesofplectranthuseckloniiconstituents
AT husseinahmeda alphaglucosidaseandalphaamylaseinhibitoryactivitiesmoleculardockingandantioxidantcapacitiesofplectranthuseckloniiconstituents